CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) saw a significant decrease in short interest during the month of October. As of October 15th, there was short interest totaling 1,339 shares, a decrease of 54.3% from the September 30th total of 2,927 shares. Based on an average daily volume of 4,208 shares, the short-interest ratio is currently 0.3 days.
CSPC Pharmaceutical Group Stock Down 4.2%
Shares of CSPC Pharmaceutical Group stock opened at C$3.94 on Friday. CSPC Pharmaceutical Group has a 12 month low of C$3.26 and a 12 month high of C$5.46. The firm’s fifty day simple moving average is C$4.62 and its 200-day simple moving average is C$4.44.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. The company researches, develops, manufactures and distributes finished pharmaceutical products and active pharmaceutical ingredients, serving hospitals, pharmacies and other healthcare channels.
Its product portfolio includes medicines for neurological, cardiovascular, oncology, anti-infective and other therapeutic areas. CSPC is known for products such as butylphthalide, used in the treatment of ischemic stroke, as well as oncology medicines, injectable therapies and a range of generic drugs.
Further Reading
- Five stocks we like better than CSPC Pharmaceutical Group
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
- The Factories Behind AI Servers Just Raised Their Outlooks—3 Contract Manufacturers to Watch
- MarketBeat Week in Review – 10/26 – 10/30
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
